AFFY Related Major News
-
Affymax (AFFY) Reports Q1 Loss of $0.71
-
Affymax, Inc. (AFFY) Posts Q4 Loss of $1.85/Share
-
Affymax (AFFY) to Cut Workforce Following OMONTYS Recall, Considers Bankruptcy
-
Affymax (AFFY) and Takeda to Recall OMONTYS after Report of Serious Hypersensitivity Reactions
-
Affymax (AFFY) Slammed after Pausing Expansion of Pilot
-
Affymax, Inc. (AFFY) Tops Q3 EPS by 4c, Comments on Outlook
-
Affymax, Inc. (AFFY) Posts Surprise Q1 Loss of 87c/Share
-
Affymax (AFFY), Takeda Get Positive ODAC Vote for Peginesatide on CKD
-
Affymax, Inc. (AFFY) Tops Q3 EPS by 4c; Boosts Q4 Expectations
-
Affymax, Inc. (AFFY) Posts Q2 EPS Loss of $0.35, Reaffirms FY11 Guidance
-
Affymax, Inc. (AFFY) Reports Q1 EPS Loss of $0.36 With $16.68 Million in Revenue
-
Affymax Inc. (AFFY) Posts Q2 EPS of $0.70, Tops Views
-
Affymax (AFFY) Reports Mixed Q1 Results
-
Affymetrix (AFFY) Posts Q1 Loss of $0.14, Misses Views
-
Affymax, Inc. (AFFY) Reports FY09 Results, Loss Narrower Y/Y
-
Affymax (AFFY) Posts Q3 Loss of $0.97, Narrower than Expected
-
Affymax (AFFY) Reports Better-Than-Expected Q2 Loss of $1.17
-
Affymax (AFFY) Reports Q2 Loss of $1.24
Back to AFFY Stock Lookup
